SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

BioNTech Reviews Next Steps for Cancer Drug After Setback

BioNTech is reviewing its next steps for a cancer drug following a setback.

BNTX

Related stories